Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

MIZOMIB 2MG
Connect with this vendor - Learn about this product

MEZOMIB 2 MG INJECTION (BORTEZOMIB 2 MG)

MEZOMIB 2

Medicine composition: Bortezomib Injection IP 2 mg

Dosage Form: Injection

Packing: 1*Vial

Market Authorization: MBA Pharmaceuticals Pvt Ltd

Country Of Origin: India

Similar to VELCADE

MEZOMIB 2 MG is used in the treatment of some types of cancers, specifically mantle cell lymphoma and multiple myeloma. The drug is an antineoplastic, thus it is used in chemotherapy. The drug blocks the function of some types of protein present in the cancer cell, which eventually destroys it.

Ask for Quote: [email protected]